{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:33:24Z","timestamp":1790213604079,"version":"4.1.0"},"reference-count":79,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 AI147714, PO1 AI098681, RO1 09083, U19AI145825"],"award-info":[{"award-number":["R21 AI147714, PO1 AI098681, RO1 09083, U19AI145825"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The fetal\/neonatal period represents both a unique window of opportunity for interventions as well as vulnerability to a number of viral infections. While<jats:italic>Herpesviruses<\/jats:italic>such as herpes simplex virus (HSV) are highly prevalent and typically of little consequence among healthy adults, they are among the most consequential infections of early life. Despite treatment with antiviral drugs, neonatal HSV (nHSV) infections can still result in significant mortality and lifelong neurological morbidity. Fortunately, newborns in our pathogen-rich world inherit some of the protection provided by the maternal immune system in the form of transferred antibodies. Maternal seropositivity, resulting in placental transfer of antibodies capable of neutralizing virus and eliciting the diverse effector functions of the innate immune system are associated with dramatically decreased risk of nHSV. Given this clear epidemiological evidence of reduced risk of infection and its sequelae, we present what is known about the ability of monoclonal antibody therapies to treat or prevent HSV infection and explore how effective antibody-based interventions in conjunction with antiviral therapy might reduce early life mortality and long-term morbidity.<\/jats:p>","DOI":"10.3389\/fimmu.2022.959603","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T07:58:12Z","timestamp":1660031892000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Monoclonal antibody therapy of herpes simplex virus: An opportunity to decrease congenital and perinatal infections"],"prefix":"10.3389","volume":"13","author":[{"given":"Iara M.","family":"Backes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Leib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret E.","family":"Ackerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.19.237149","article-title":"Herpes simplex virus: global infection prevalence and incidence estimates, 2016","volume":"98","author":"James","year":"2020","journal-title":"Bull World Health Organ"},{"key":"B2","article-title":"DNA Viruses. seventh edition","volume-title":"New York Philadelphia Baltimore London Buenos Aires Hong Kong Sydney Tokyo","author":"Fields","year":""},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199102143240703","article-title":"A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. infectious diseases collaborative antiviral study group","volume":"324","author":"Whitley","year":"1991","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1542\/peds.108.2.230","article-title":"Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections","volume":"108","author":"Kimberlin","year":"2001","journal-title":"PEDIATRICS"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000219749.96274.15","article-title":"Valacyclovir prophylaxis to prevent recurrent herpes at delivery: A randomized clinical trial","volume":"108","author":"Sheffield","year":"2006","journal-title":"Obstet Gynecol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003509","article-title":"Oral acyclovir suppression and neurodevelopment after neonatal herpes","volume":"365","author":"Kimberlin","year":"2011","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piab105","article-title":"Neonatal herpes simplex virus infection: Epidemiology and outcomes in the modern era","volume":"11","author":"Melvin","year":"2022","journal-title":"J Pediatr Infect Dis Soc"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199708213370801","article-title":"The acquisition of herpes simplex virus during pregnancy","volume":"337","author":"Brown","year":"1997","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(16)30362-X","article-title":"First estimates of the global and regional incidence of neonatal herpes infection","volume":"5","author":"Looker","year":"2017","journal-title":"Lancet Glob Health"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e193","DOI":"10.1097\/AOG.0000000000003840","article-title":"Management of genital herpes in pregnancy: ACOG practice bulletin, number 220","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.2.203","article-title":"Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant","volume":"289","author":"Brown","year":"2003","journal-title":"JAMA"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0807633","article-title":"Maternal and neonatal herpes simplex virus infections","volume":"361","author":"Corey","year":"2009","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2020.03.004","article-title":"Vaccines to prevent genital herpes","volume":"220","author":"Egan","year":"2020","journal-title":"Transl Res J Lab Clin Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.798927","article-title":"Developments in vaccination for herpes simplex virus","volume":"12","author":"Krishnan","year":"2021","journal-title":"Front Microbiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1053\/j.semperi.2007.01.003","article-title":"Herpes simplex virus infections of the newborn","volume":"31","author":"Kimberlin","year":"2007","journal-title":"Semin Perinatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1700794","article-title":"High incidence of herpes simplex virus-1 in cord blood and placenta infection of women in southern Brazil","volume":"42","author":"Avila","year":"2020","journal-title":"Rev Bras Ginecol E Obstetr\u00edcia RBGO Gynecol Obstet"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.23817","article-title":"Herpes simplex virus: prevalence in placental tissue and incidence in neonatal cord blood samples","volume":"86","author":"Finger-Jardim","year":"2014","journal-title":"J Med Virol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ijos.2016.3","article-title":"New strategies against drug resistance to herpes simplex virus","volume":"8","author":"Jiang","year":"2016","journal-title":"Int J Oral Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/0966-842X(94)90652-1","article-title":"Acyclovir-resistant, pathogenic herpesviruses","volume":"2","author":"Coen","year":"1994","journal-title":"Trends Microbiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.16.1.114-128.2003","article-title":"Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy","volume":"16","author":"Bacon","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199102143240704","article-title":"Predictors of morbidity and mortality in neonates with herpes simplex virus infections. the national institute of allergy and infectious diseases collaborative antiviral study group","volume":"324","author":"Whitley","year":"1991","journal-title":"N Engl J Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1542\/peds.66.4.489","article-title":"The natural history of herpes simplex virus infection of mother and newborn","volume":"66","author":"Whitley","year":"1980","journal-title":"Pediatrics"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/00006254-198104000-00012","article-title":"Relationship of antibody to outcome in neonatal herpes simplex virus infections","volume":"36","author":"Yeager","year":"1981","journal-title":"Obstet Gynecol Surv"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/160.5.770","article-title":"Neonatal antibody-dependent cellular cytotoxic antibody levels are associated with the clinical presentation of neonatal herpes simplex virus infection","volume":"160","author":"Kohl","year":"1989","journal-title":"J Infect Dis"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200003233421203","article-title":"Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons","volume":"342","author":"Wald","year":"2000","journal-title":"N Engl J Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1056\/NEJMoa1103151","article-title":"Efficacy results of a trial of a herpes simplex vaccine","volume":"366","author":"Belshe","year":"2012","journal-title":"N Engl J Med"},{"key":"B27","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.104.2.289","article-title":"A prospective study of chronic herpes simplex virus infection and recurrent herpes labialis in humans","volume":"104","author":"Douglas","year":"1970","journal-title":"J Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0166-3542(95)00037-m","article-title":"Th1\/Th2-like immunity and resistance to herpes simplex labialis","volume":"28","author":"Spruance","year":"1995","journal-title":"Antiviral Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.07107-11","article-title":"Immunodominant \u201cAsymptomatic\u201d herpes simplex virus 1 and 2 protein antigens identified by probing whole-ORFome microarrays with serum antibodies from seropositive asymptomatic versus symptomatic individuals","volume":"86","author":"Dasgupta","year":"2012","journal-title":"J Virol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500872","article-title":"NK cell and ig interplay in defense against herpes simplex virus type 1: Epistatic interaction of CD16A and IgG1 allotypes of variable affinities modulates antibody-dependent cellular cytotoxicity and susceptibility to clinical reactivation","volume":"195","author":"Moraru","year":"2015","journal-title":"J Immunol"},{"key":"B31","unstructured":"JiangY United States \u2013 New HampshireDartmouth CollegeViral corruption of immune privilege: Immunity and pathology in the cornea and nervous system after HSV-1 infection. [Ph.D.]2017"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau6039","article-title":"Maternal immunization confers protection against neonatal herpes simplex mortality and behavioral morbidity","volume":"11","author":"Patel","year":"2019","journal-title":"Sci Transl Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"729\u201338","DOI":"10.1093\/infdis\/jiz521","article-title":"Murine model of maternal immunization demonstrates protective role for antibodies that mediate antibody-dependent cellular cytotoxicity in protecting neonates from herpes simplex virus type 1 and type 2","volume":"221","author":"Kao","year":"2019","journal-title":"J Infect Dis"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02163-19","article-title":"Trivalent glycoprotein subunit vaccine prevents neonatal herpes simplex virus mortality and morbidity","volume":"94","author":"Patel","year":"2020","journal-title":"J Virol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00678-17","article-title":"Maternal antiviral immunoglobulin accumulates in neural tissue of neonates to prevent HSV neurological disease","volume":"8","author":"Jiang","year":"2017","journal-title":"mBio"},{"key":"B36","first-page":"188","volume-title":"Harnessing maternal humoral immunity to prevent neonatal herpes neurological sequela. [Ph.D.]","author":"Patel","year":"2020"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-83-11-2797","article-title":"Modification of primary and recurrent genital herpes in guinea pigs by passive immunization","volume":"83","author":"Bourne","year":"2002","journal-title":"J Gen Virol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-71-3-681","article-title":"Passive immunization protects the mouse eye from damage after herpes simplex virus infection by limiting spread of virus in the nervous system","volume":"71","author":"Shimeld","year":"1990","journal-title":"J Gen Virol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2015.12.016","article-title":"A human open field test reveals thigmotaxis related to agoraphobic fear","volume":"80","author":"Walz","year":"2016","journal-title":"Biol Psychiatry"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-63-2-475","article-title":"Dissemination of herpes simplex virus in nude mice after intracutaneous inoculation and effect of antibody on the course of infection","volume":"63","author":"Kino","year":"1982","journal-title":"J Gen Virol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/256495a0","article-title":"Continuous cultures of fused cells secreting antibody of predefined specificity","volume":"256","author":"K\u00f6hler","year":"1975","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.37.3.1132-1137.1982","article-title":"Protection against lethal challenge of BALB\/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2","volume":"37","author":"Balachandran","year":"1982","journal-title":"Infect Immun"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1128\/iai.34.1.192-199.1981","article-title":"Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease","volume":"34","author":"Dix","year":"1981","journal-title":"Infect Immun"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114695","article-title":"Analysis of the role of antibody-dependent cellular cytotoxic antibody activity in murine neonatal herpes simplex virus infection with antibodies to synthetic peptides of glycoprotein d and monoclonal antibodies to glycoprotein b","volume":"86","author":"Kohl","year":"1990","journal-title":"J Clin Invest"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1159\/000150219","article-title":"Different mechanisms of protection by monoclonal and polyclonal antibodies during the course of herpes simplex virus infection","volume":"32","author":"Eis-H\u00fcbinger","year":"1991","journal-title":"Intervirology"},{"key":"B46","unstructured":"HarfeldtE LakeP NottageB OstbergLG Monoclonal antibody to herpes simplex virus and cell line producing same1997"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.1985.tb00812.x","article-title":"Passive immunization of mice with monoclonal antibodies to glycoprotein gB of herpes simplex virus","volume":"29","author":"Kino","year":"1985","journal-title":"Microbiol Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/0166-3542(86)90003-3","article-title":"Ability of monoclonal antibody to herpes simplex virus glycoprotein gB to promote healing of herpetic skin lesions in nude mice","volume":"6","author":"Yamamoto","year":"1986","journal-title":"Antiviral Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.56.3.930-937.1985","article-title":"Passive immune protection by herpes simplex virus-specific monoclonal antibodies and monoclonal antibody-resistant mutants altered in pathogenicity","volume":"56","author":"K\u00fcmel","year":"1985","journal-title":"J Virol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/163.2.263","article-title":"Protection against zosteriform spread of herpes simplex virus by monoclonal antibodies","volume":"163","author":"Mester","year":"1991","journal-title":"J Infect Dis"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1128\/iai.38.1.168-174.1982","article-title":"Use of monoclonal antibodies for analysis of antibody-dependent immunity to ocular herpes simplex virus type 1 infection","volume":"38","author":"Rector","year":"1982","journal-title":"Infect Immun"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.53.3.944-948.1985","article-title":"Role of antibody in primary and recurrent herpes simplex virus infection","volume":"53","author":"Simmons","year":"1985","journal-title":"J Virol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3109\/02713688909000030","article-title":"Quantitation of purified monoclonal antibody needed to prevent HSV-1 induced stromal keratitis in mice","volume":"8","author":"Lausch","year":"1989","journal-title":"Curr Eye Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.65.11.6008-6014.1991","article-title":"Anti-glycoprotein d monoclonal antibody protects against herpes simplex virus type 1-induced diseases in mice functionally depleted of selected T-cell subsets or asialo GM1+ cells","volume":"65","author":"Staats","year":"1991","journal-title":"J Virol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00411-17","article-title":"Monoclonal antibodies, derived from humans vaccinated with the RV144 HIV vaccine containing the HVEM binding domain of herpes simplex virus (HSV) glycoprotein d, neutralize HSV infection, mediate antibody-dependent cellular cytotoxicity, and protect mice from ocular challenge with HSV-1","volume":"91","author":"Wang","year":"2017","journal-title":"J Virol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa648","article-title":"Respiratory syncytial virus (RSV) neutralizing antibodies at birth predict protection from RSV illness in infants in the first 3 months of life","volume":"73","author":"Buchwald","year":"2021","journal-title":"Clin Infect Dis"},{"key":"B57","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.143.10.3250","article-title":"Exogenous C1q reconstitutes resident but not inflammatory mouse peritoneal macrophages for fc receptor-dependent cellular cytotoxicity and phagocytosis. relationship to endogenous C1q availability","volume":"143","author":"Leu","year":"1989","journal-title":"J Immunol"},{"key":"B58","unstructured":"AckermanM NimmerjahnF AmsterdamAcademic PressAntibody Fc : Linking adaptive and innate immunity2013"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(81)80829-3","article-title":"Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level","volume":"98","author":"Glezen","year":"1981","journal-title":"J Pediatr"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1542\/peds.102.3.531","article-title":"Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants","volume":"102","year":"1998","journal-title":"Pediatrics"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02110","article-title":"The roles of host and viral antibody fc receptors in herpes simplex virus (HSV) and human cytomegalovirus (HCMV) infections and immunity","volume":"10","author":"Jenks","year":"2019","journal-title":"Front Immunol"},{"key":"B62","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.128.3.1107","article-title":"Protection of newborn mice from a lethal herpes simplex virus infection by human interferon, antibody, and leukocytes","volume":"128","author":"Kohl","year":"1982","journal-title":"J Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1101\/2022.01.12.476098","article-title":"Maternally transferred monoclonal antibodies protect neonatal mice from herpes simplex virus-induced mortality and morbidity","author":"Backes","year":"2022","journal-title":"bioRxiv"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1107\/S0907444913016776","article-title":"Structural basis for the antibody neutralization of Herpes simplex virus","volume":"69","author":"Lee","year":"2013","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"B65","unstructured":"LaiJ-S LinY-S ChanW-E Anti-herpes simplex virus antibodies2010"},{"key":"B66","unstructured":"LaiJ-S ChanW-E Anti-herpes simplex virus antibodies and methods of use thereof2013"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2016.03.003","article-title":"Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes","volume":"21","author":"Clementi","year":"2016","journal-title":"Drug Discovery Today"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1996.0011","article-title":"Protection of nude mice by passive immunization with a type-common human recombinant monoclonal antibody against HSV","volume":"215","author":"Sanna","year":"1996","journal-title":"Virology"},{"key":"B69","doi-asserted-by":"publisher","first-page":"e1003495","DOI":"10.1371\/journal.pmed.1003495","article-title":"Safety, acceptability, and pharmacokinetics of a monoclonal antibody-based vaginal multipurpose prevention film (MB66): A phase I randomized trial","volume":"18","author":"Politch","year":"2021","journal-title":"PLoS Med"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1220019110","article-title":"Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibody","volume":"110","author":"Krawczyk","year":"2013","journal-title":"Proc Natl Acad Sci"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01924-10","article-title":"Impact of valency of a glycoprotein b-specific monoclonal antibody on neutralization of herpes simplex virus","volume":"85","author":"Krawczyk","year":"2011","journal-title":"J Virol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00430-010-0174-x","article-title":"Characterisation of the epitope for a herpes simplex virus glycoprotein b-specific monoclonal antibody with high protective capacity","volume":"200","author":"D\u00e4umer","year":"2011","journal-title":"Med Microbiol Immunol (Berl)"},{"key":"B73","doi-asserted-by":"publisher","first-page":"e0116800","DOI":"10.1371\/journal.pone.0116800","article-title":"Prevention of herpes simplex virus induced stromal keratitis by a glycoprotein b-specific monoclonal antibody","volume":"10","author":"Krawczyk","year":"2015","journal-title":"PoS One"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.1.355","article-title":"Recombinant human fab to glycoprotein d neutralizes infectivity and prevents cell-to-cell transmission of herpes simplex viruses 1 and 2","volume":"91","author":"Burioni","year":"1994","journal-title":"vitro Proc Natl Acad Sci"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1996.0589","article-title":"Topically applied human recombinant monoclonal IgG1Antibody and its fab and F(ab\u2032)2Fragments protect mice from vaginal transmission of HSV-2","volume":"225","author":"Zeitlin","year":"1996","journal-title":"Virology"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-018-0054-z","article-title":"Herpes simplex virus-binding IgG traps HSV in human cervicovaginal mucus across the menstrual cycle and diverse vaginal microbial composition","volume":"11","author":"Schroeder","year":"2018","journal-title":"Mucosal Immunol"},{"key":"B77","article-title":"Pricing of monoclonal antibody therapies: higher if used for cancer","volume":"24","author":"Hernandez","year":"2018","journal-title":"Am J Manag Care"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2011-0177","article-title":"Delayed acyclovir therapy and death among neonates with herpes simplex virus infection","volume":"128","author":"Shah","year":"2011","journal-title":"PEDIATRICS"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2005.00540.x","article-title":"Type-specific screening for asymptomatic herpes infection in pregnancy: a decision analysis","volume":"112","author":"Cleary","year":"2005","journal-title":"BJOG Int J Obstet Gynaecol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.959603\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T01:47:31Z","timestamp":1676339251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.959603\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,9]]},"references-count":79,"alternative-id":["10.3389\/fimmu.2022.959603"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.959603","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,9]]},"article-number":"959603"}}